Showing results (51-60 of 588) with videos related to
Sort By:
Pageof 59
Cancer|October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovaryT C Hamilton, R F Ozols, D L LongoAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?T C Hamilton, J S Berek, S B KayeOncology (Williston Park, N.Y.)|March 1, 1990
Multidrug resistance to alkylating agents and platinum compounds: state of our knowledgeT C Hamilton, R F Ozols, M B DabrowMolecular and Cellular Endocrinology|February 1, 1994
Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cellsC H Chien, F F Wang, T C HamiltonPharmacology & Therapeutics|January 1, 1990
Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systemsR P Perez, T C Hamilton, R F OzolsThe Journal of Endocrinology|September 1, 1976
Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal womenG V Groom, K GriffithsBritish Journal of Pharmacology|January 1, 1976
Prolonged effects of p-chlorophenylalanine on the blood pressure of conscious normotensive and DOCA/saline hypertensive ratsR E Buckingham, T C Hamilton, R A MooreDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 15, 2006
Recent insights into platinum drug resistance in cancerS W Johnson, K V Ferry, T C HamiltonAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
New non-cytotoxic approaches to ovarian cancerS B Kaye, E A Eisenhauer, T C HamiltonCurrent Opinion in Oncology|November 1, 1993
Platinum analogues in preclinical and clinical developmentT C Hamilton, P J O'Dwyer, R F OzolsPageof 59